Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains
Pharmacology Biochemistry and Behavior · 2026-09 · 266 · 174230
DOI: 10.1016/j.pbb.2026.174230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2026-09. Verfasst von Natalli Granzotto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex. Die Arbeit nennt 68 Literaturangaben. Gefördert von: ICREA, Coordination for the improvement of Higher Education Personnel, Spain Ministry of Science Innovation and Universities.
Abstract (Originalsprache)
Disruptions in glutamatergic signaling within the prefrontal cortex (PFC) have been increasingly implicated in the pathophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD). The Spontaneously Hypertensive Rat (SHR) is widely recognized as the standard animal model for ADHD, though it presents certain experimental limitations. To overcome these, we developed the congenic strain SHR.LEW-(D4Rat76-D4Mgh11) (SLA16). Here, we tested the hypothesis that SHR and SLA16 male rats differ in their PFC sensitivity to NMDA receptor (NMDAR) modulation by MK-801 (a non-selective NMDAR antagonist) and ifenprodil (a GluN2B-selective antagonist). Behavioral performance was evaluated using the open-field and object recognition tests following intra-PFC microinjections. Pharmacological manipulations revealed distinct strain-dependent responses, indicating differential NMDAR sensitivity. Although GluN2A and GluN2B protein levels in the PFC did not differ between strains, SLA16 rats exhibited reduced hippocampal GluN2A and GluN2B expression, accompanied by enhanced hyperactivity and impulsivity compared to SHR. These findings highlight the contribution of NMDAR-mediated glutamatergic mechanisms to ADHD-related behavioral phenotypes and support the SLA16 strain as a model for investigating the molecular and neural pathways underlying this disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil.
- Graduate Program in Developmental and Cellular Biology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil.
- Graduate Program in Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil; Graduate Program in Neuroscience, Center of Biological Sciences, Federal University of Santa…
- Department of Psychiatry and Legal Medicine, Autonomous University of Barcelona, Barcelona, Spain.
- Graduate Program in Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, Brazil; Graduate Program in Developmental and Cellular Biology, Center of Biological Sciences, Federa…
Förderung
- ICREA
- Coordination for the improvement of Higher Education Personnel
- Spain Ministry of Science Innovation and Universities
Zitieren
APA
Granzotto, N., Boeder, A. M., de Araújo, J. F. P., Soares, E. S., Cimarosti, H., Bertoglio, L. J., Fernández-Teruel, A., & Izídio, G. S. (2026). Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains. Pharmacology Biochemistry and Behavior, 266, 174230. https://doi.org/10.1016/j.pbb.2026.174230
Vancouver
Granzotto N, Boeder AM, de Araújo JFP, Soares ES, Cimarosti H, Bertoglio LJ, et al. Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains. Pharmacology Biochemistry and Behavior. 2026;266:174230. doi:10.1016/j.pbb.2026.174230
BibTeX
@article{Granzotto2026,
author = {Granzotto, Natalli and Boeder, Ariela Maína and de Araújo, Julia Fernandez Puñal and Soares, Ericks Sousa and Cimarosti, Helena and Bertoglio, Leandro José and Fernández-Teruel, Alberto and Izídio, Geison Souza},
title = {Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains},
journal = {Pharmacology Biochemistry and Behavior},
year = {2026},
volume = {266},
pages = {174230},
doi = {10.1016/j.pbb.2026.174230}
}
EUVIMED